Literature DB >> 21358665

Randomized studies of PSA screening: an opinion.

Oliver Sartor1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21358665      PMCID： PMC3739343          DOI： 10.1038/aja.2011.12

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  6 in total

1.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

2.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

3.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

4.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  The National Cancer Data Base report on longitudinal observations on prostate cancer.

Authors:  C J Mettlin; G P Murphy; R Ho; H R Menck
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

6.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506
  6 in total
  3 in total

1.  Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer.

Authors:  Hui-Jie Jia; Yang Li; Jin-Guo Wang; Ling Zhang; Hai-Tao Zhang; Xue-Jian Zhao; Masaaki Kuwahara
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

Review 2.  Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.

Authors:  Jiajia Chen; Daqing Zhang; Wenying Yan; Dongrong Yang; Bairong Shen
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

Review 3.  Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.

Authors:  Petra Hudler; Nina Kocevar; Radovan Komel
Journal:  ScientificWorldJournal       Date:  2014-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.